Announced Fri, 25 Sept, 2026 · 18:21 IST
Bal Pharma 39th AGM: All 7 resolutions passed, Rs 1.20 dividend approved
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.7%1-day move
₹107.00
prior close
₹108.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.9-1.5-1.9+0.6+4.7+2.4-0.7+0.4-5.2-10.8————
Up moveDown movePending
AI summary
Bal Pharma held its 39th AGM on Sept 24, 2026 via video conferencing. All 7 resolutions were passed with 99.44 percent to 100 percent approval. Key items include adoption of FY26 audited financial statements, declaration of a Rs 1.20 per share dividend, re-appointment of Mr. Ravindra Kumar Kothari as Director, ratification of Cost Auditor remuneration, renewal of the contract with Desa Marketing International, and designation changes for two directors.
Likely market impact
Shareholders approved a Rs 1.20 per share dividend for FY26 plus routine governance changes including director redesignations.